Pulse Biosciences, Inc. Insider Trading

PLSE

⊜ Compare

Last 12 months

Insiders bought $13.8M and sold $2.93M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

+$10.9M

5 buys · 3 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

3 / 1

executives and directors

Last open-market buy

Sep 2026

Sep 1, 2026

Get an email when PLSE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 31 – Sep 1	Liane Rae Teplitsky Chief Operating Officer	Bought 2 parts	2,025	$49.37 average	100K	98%	Form 4
Aug 26 – 28	Liane Rae Teplitsky Chief Operating Officer	Bought 2 parts	2,070	$48.29 average	100K	New	Form 4
May 11	Robert W Duggan Director	Bought	660,233	$19.69	$13M	1.4%	Form 4
May 11	Paul A Laviolette Chief Executive Officer	Bought	15,000	$19.69	295K	New	Form 4
May 11	Paul A Laviolette Chief Executive Officer	Bought	15,000	$19.69	295K	1773%	Form 4
Feb 18	Kevin Patrick Danahy Chief Commercial Officer	Sold10b5-1 plan	5,000	$23.64	118K	10%	Form 4
Feb 12 – 17	Kevin Patrick Danahy Chief Commercial Officer	Sold10b5-1 plan 3 parts	60,000	$23.51 average	$1.41M	58%	Form 4
Feb 9 – 11	Kevin Patrick Danahy Chief Commercial Officer	Sold10b5-1 plan 3 parts	60,000	$23.39 average	$1.4M	58%	Form 4
Oct 2, 2025	Kevin Patrick Danahy Chief Commercial Officer	Sold10b5-1 plan	4,600	$18.53	85K	9.6%	Form 4
Sep 18, 2025 – Sep 19, 2025	Kevin Patrick Danahy Chief Commercial Officer	Sold10b5-1 plan 2 parts	20,400	$18.49 average	377K	32%	Form 4
Sep 16, 2025 – Sep 17, 2025	Darrin Uecker Chief Technology Officer	Sold10b5-1 plan 2 parts	45,000	$16.25 average	731K	14%	Form 4
Sep 11, 2025 – Sep 15, 2025	Darrin Uecker Chief Technology Officer	Sold10b5-1 plan 3 parts	75,000	$14.96 average	$1.12M	38%	Form 4
Sep 10, 2025	Robert W Duggan Director	Bought	34,659	$14.66	508K	<0.1%	Form 4
Jun 12, 2025 – Jun 13, 2025	Darrin Uecker Chief Technology Officer	SoldNo plan 2 parts	30,000	$16.19 average	486K	20%	Form 4
Dec 13, 2024	Robert W Duggan Director	Bought	55,256	$17.18	949K	0.1%	Form 4
Dec 12, 2024	Robert W Duggan Director	Bought	45,404	$17.13	778K	0.1%	Form 4
Dec 11, 2024	Burke Thomas Barrett Other	SoldNo plan	50,000	$17.42	871K	44%	Form 4
Dec 11, 2024	Robert W Duggan Director	Bought 2 parts	56,054	$17.35 average	972K	0.1%	Form 4

Aug 31 – Sep 1
Liane Rae Teplitsky
Chief Operating Officer · bought 2,025 at avg $49.37
100K
98% of stake
Aug 26 – 28
Liane Rae Teplitsky
Chief Operating Officer · bought 2,070 at avg $48.29
100K
New position
May 11
Robert W Duggan
Director · bought 660,233 at $19.69
$13M
1.4% of stake
May 11
Paul A Laviolette
Chief Executive Officer · bought 15,000 at $19.69
295K
New position
May 11
Paul A Laviolette
Chief Executive Officer · bought 15,000 at $19.69
295K
1773% of stake
Feb 1810b5-1 plan
Kevin Patrick Danahy
Chief Commercial Officer · sold 5,000 at $23.64
118K
10% of stake
Feb 12 – 1710b5-1 plan
Kevin Patrick Danahy
Chief Commercial Officer · sold 60,000 at avg $23.51
$1.41M
58% of stake
Feb 9 – 1110b5-1 plan
Kevin Patrick Danahy
Chief Commercial Officer · sold 60,000 at avg $23.39
$1.4M
58% of stake
Oct 2, 202510b5-1 plan
Kevin Patrick Danahy
Chief Commercial Officer · sold 4,600 at $18.53
85K
9.6% of stake
Sep 18, 2025 – Sep 19, 202510b5-1 plan
Kevin Patrick Danahy
Chief Commercial Officer · sold 20,400 at avg $18.49
377K
32% of stake
Sep 16, 2025 – Sep 17, 202510b5-1 plan
Darrin Uecker
Chief Technology Officer · sold 45,000 at avg $16.25
731K
14% of stake
Sep 11, 2025 – Sep 15, 202510b5-1 plan
Darrin Uecker
Chief Technology Officer · sold 75,000 at avg $14.96
$1.12M
38% of stake
Sep 10, 2025
Robert W Duggan
Director · bought 34,659 at $14.66
508K
<0.1% of stake
Jun 12, 2025 – Jun 13, 2025No plan
Darrin Uecker
Chief Technology Officer · sold 30,000 at avg $16.19
486K
20% of stake
Dec 13, 2024
Robert W Duggan
Director · bought 55,256 at $17.18
949K
0.1% of stake
Dec 12, 2024
Robert W Duggan
Director · bought 45,404 at $17.13
778K
0.1% of stake
Dec 11, 2024No plan
Burke Thomas Barrett
Other · sold 50,000 at $17.42
871K
44% of stake
Dec 11, 2024
Robert W Duggan
Director · bought 56,054 at avg $17.35
972K
0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PLSE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PLSE

CompareIntrinsic value

PETVPetvivo Holdings Inc

$0.60+1.69%26

VTAKCatheter Precision, Inc.

$0.56-5.08%40

SINTSintx Technologies Inc.

$1.66-3.49%10

HRGNHarvard Apparatus Regenerative Technology Inc.

$2.30+0.00%10

EMEDElectromedical Technologies Inc.

$0.00+0.00%26

EBRCZEBR Systems, Inc.

$0.08+0.00%0

CODXCo-Diagnostics Inc.

$0.36-5.00%10

ICUSeastar Medical Holding Corporation

$2.04+2.00%20

Held by ETFs

PLSE is in 20 US ETFs. The largest of them, with PLSE's weight in each:

Spot a number that looks wrong? Check it in PLSE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PLSE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.